Background: Adenomyosis and endometriosis are common gynecological conditions associated with infertility and potential impairment of ovarian reserve. Ovarian reserve is evaluated by important markers such as serum anti-Müllerian hormone (AMH) and antral follicle count (AFC). This study aimed to compare serum AMH levels and AFC among infertile women with adenomyosis and endometriosis. Methods: The comparative cross-sectional study was carried out at Abbasi Shaheed Hospital, Karachi, from 1st December 2025 to 31st May 2026. Eighty infertile women aged 20-40 years were consecutively sampled and divided into two groups, adenomyosis (n=40) and endometriosis (n=40). Immunoassay was used to determine AMH, and transvaginal ultrasonography was used for AFC. Data were analyzed using SPSS version 26, with a significance level of p≤0.05. Results: Women with endometriosis demonstrated significantly lower mean serum AMH levels (2.08 ± 1.14 vs. 3.42 ± 1.26 ng/mL; p<0.001) and total AFC (5.92 ± 2.34 vs. 8.15 ± 2.61; p<0.001) compared with women with adenomyosis. A high level of significant positive correlation is observed between AMH and AFC in both groups (r=0.672 and r=0.741, respectively; p<0.001). The increase in age and endometriosis were independent risk factors for decreased AMH levels in the multivariable analysis. Conclusions: The ovarian reserve parameters were significantly lower in women with endometriosis compared to women with adenomyosis in infertile women. The joint evaluation of AMH and AFC might help in the estimation of ovarian reserve and personalized fertility counseling.
Infertility is a significant reproductive problem that impacts millions of women worldwide and has significant physical, psychological, and socioeconomic implications.[1] According to the World Health Organization, approximately 17.5% of the adult population experiences infertility during their lifetime, highlighting the need for improved evaluation of female reproductive health.[2] Infertility can be caused by a variety of gynecological issues, and in recent times, subfertility caused by adenomyosis and endometriosis has been the subject of considerable interest due to its possible impact on ovarian reserve, follicular development, implantation, and reproductive outcomes.[3]
Endometriosis is an inflammatory condition that occurs in the female body, involving the presence of tissue similar to the endometrium outside the uterine cavity, and is estrogen-dependent.[4] It occurs in about 10% of women of reproductive age and is commonly seen in association with pelvic inflammation, ovarian endometriomas, and changes in the normal process of follicular development that can lead to infertility.[5] Reduced ovarian reserve can be caused by the inflammatory microenvironment, by some increase in oxidative stress, and by some structural damage to the ovarian tissue, especially if the woman has an endometrioma or previous tubal surgery of the ovary.[6] Adenomyosis is also increasingly known as an important cause of female infertility.[7] It can affect uterine contractility, receptivity of the endometrium, embryo implantation, and early pregnancy maintenance.[7] Recent studies indicate that adenomyosis may also be linked to changes in ovarian reserve, but the extent and relevance of this association are not consistent.[8, 9]
The evaluation of ovarian reserve has become an integral part of the assessment of infertility that gives an idea of the remaining follicular pool and helps in the counselling and treatment planning of infertile women.[10] A biochemical marker such as anti-Müllerian hormone (AMH) that is produced by granulosa cells of pre-antral and small antral follicles is a reliable marker of ovarian reserve and can be measured separately from most of the menstrual cycle.[11] Antral follicle count (AFC) is a direct sonographic assessment of the pool of recruitable follicles, which is measured by transvaginal ultrasonography.[12] Although both parameters are widely used in reproductive medicine, they assess ovarian reserve through different approaches and may provide complementary information. The interpretation is especially critical in women with endometriosis and adenomyosis, where structural and inflammatory changes can impact ovarian function.
Clinically, recent studies have shown that women suffering from these two conditions have differences in their ovarian reserve. Yin et al. 2024 found significantly decreased AMH and AFC levels in both the adenomyosis and ovarian endometriosis groups compared to healthy women (N=150). Specifically, the ovarian endometriosis group had the greatest decreases in AMH (1.25 ± 1.34 ng/mL), and AFC (2.53 ± 1.19), respectively, compared with adenomyosis (3.78 ± 1.08 ng/mL; 8.05 ± 2.49, respectively).[8]
A similar 2024 cohort study of 1,037 women undergoing assisted reproductive treatment identified that women with sonographic evidence of adenomyosis had lower AMH and AFC than women without the sonographic evidence.[13] However, the relationship between adenomyosis and ovarian reserve is still not fully understood, and variations in the clinical features of the disease, age, other pelvic diseases, and the presence of ovarian involvement could affect the results.
Despite these data, there are limited direct comparisons of AMH and AFC specifically between infertile women with adenomyosis and infertile women with endometriosis. In addition, the evaluation of the ovarian reserve in endometriosis is complicated by the severity of the disease, presence of ovarian endometrioma, ovarian lateralization, and previous surgery. Younis and Taylor (2024) pointed out that the risk of ovarian reserve impairment after endometrioma surgery might be higher for AMH than for AFC, and thus, both biochemical and sonographic parameters should be taken into account. Thus, it would be clinically relevant to compare these parameters directly in women with adenomyosis and endometriosis and gain insight into ovarian reserve differences between these two conditions. The present study was designed to compare serum AMH levels and AFC in infertile women with adenomyosis and endometriosis to see if there are different patterns of ovarian reserve impairment between these two conditions.
A comparative cross-sectional study was conducted. The study was carried out at the Department of Obstetrics and Gynaecology, Abbasi Shaheed Hospital, Karachi. The study lasted for 6 months, starting 1st December 2025 to 31st May 2026.
A sample size calculation was performed using the WHO-recommended OpenEpi calculator for comparing two independent means. In a previous study by Yin et al. (2024), the average serum AMH levels were found to be 3.78 ± 1.08 ng/mL in women with adenomyosis and 1.25 ± 1.34 ng/mL in women with ovarian endometriosis.[8] The calculated sample size was about 4 participants/group with a 95% confidence level, 80% power, and equal allocation. However, considering the unusually large effect size reported in the reference study and to ensure a more representative sample, a pragmatic sample of 80 participants was selected, comprising 40 women in each group.
The sampling method adopted was non-probability consecutive sampling. All the women who were observed during the study period in the outpatient department were evaluated and were included in the study until the desired sample size was obtained. The participants were divided into two groups based on clinical and imaging diagnosis. Group I consisted of infertile female patients with the diagnosis of adenomyosis, and Group II consisted of infertile women with the diagnosis of endometriosis.
Females between 20 and 40 years of age who were experiencing primary or secondary infertility (i.e., inability to conceive despite regular, unprotected sexual intercourse for at least 12 months) were included. Women who were diagnosed with adenomyosis on transvaginal ultrasonography were enrolled in Group I, and women who were diagnosed with endometriosis on transvaginal ultrasonography and/or magnetic resonance imaging (MRI) were enrolled in Group II.
Informed written consent was given by women with intact uterus and ovary. Polycystic ovarian syndrome, premature ovarian insufficiency, previous diagnosis of diminished ovarian reserve, prior surgery of the ovary (cystectomy or oophorectomy), history of chemotherapy or pelvic radiotherapy, ovarian malignancy, or other important ovarian pathology were excluded. Women who had been taking hormonal contraceptives, gonadotropin-releasing hormone analogues, or other hormonal fertility treatments within the three months before the study were also not included. Women with coexisting adenomyosis and endometriosis, pregnant women, and nursing women were excluded.
After obtaining approval from the institutional ethical review committee, eligible women attending the Department of Obstetrics and Gynaecology, Abbasi Shaheed Hospital, Karachi, were approached for participation. All study objectives and procedures were explained, and written informed consent was obtained from all participants.
A structured proforma was used to record demographic and clinical details such as age, BMI, type of infertility, duration of infertility, menstrual history, as well as parity and previous reproductive history. Adenomyosis was diagnosed on the basis of characteristic features of the myometrium seen during transvaginal ultrasonography, such as myometrial cysts, asymmetrical thickening of the myometrium, hyperechoic islands, and irregularity of the junctional zone. Transvaginal ultrasonography and/or MRI were used to diagnose endometriosis. Ovarian endometriomas were also noted, as well as their size and laterality.
AMH levels were determined by a standard immunoassay in the serum and reported as ng/mL. Samples of blood were drawn as per the laboratory protocol, preferably in the early follicular phase. The number of antral follicles was diagnosed using transvaginal ultrasonography, preferably on days 2 to 5 of the menstrual cycle. Follicle count of 2–10 mm was performed in both ovaries, and the overall bilateral AFC was taken. Examinations were conducted through ultrasound by an experienced sonologist and following a standardised examination protocol. Then, the level of AMH in the serum and AFC were compared between the two study groups.
The data were analyzed using the Statistical Package for the Social Sciences (SPSS) version 26. The normality of quantitative variables was tested using the Shapiro–Wilk test. Normally distributed variables such as age, BMI, serum AMH, and AFC were reported as mean ± standard deviation. Qualitative variables, including type of infertility, parity, and laterality of endometriosis, were expressed as frequencies and percentages. An independent-samples t-test was applied to compare mean AMH levels and AFC between the two groups for normally distributed data. Multiple linear regression analysis was conducted to control for potential confounding factors, such as age, BMI, duration of infertility, and characteristics of ovarian endometrioma. A p-value of <0.05 indicated statistical significance.
A total of 80 infertile women were included, comprising 40 women with adenomyosis and 40 with endometriosis. Baseline demographic characteristics showed differences in age and BMI between the groups, while infertility-related characteristics were comparable (Table 1).
Table 1. Demographic and baseline characteristics of study participants (N = 80)
|
Variable |
Adenomyosis (n=40) |
Endometriosis (n=40) |
p-value |
|
Age (years), mean ± SD |
33.2 ± 4.5 |
30.8 ± 4.2 |
0.015 |
|
BMI (kg/m²), mean ± SD |
27.1 ± 3.8 |
25.4 ± 3.5 |
0.041 |
|
Primary infertility, n (%) |
24 (60.0) |
29 (72.5) |
0.230 |
|
Secondary infertility, n (%) |
16 (40.0) |
11 (27.5) |
0.230 |
|
Duration of infertility (years), mean ± SD |
4.1 ± 2.0 |
4.5 ± 2.3 |
0.412 |
|
Nulliparous, n (%) |
27 (67.5) |
31 (77.5) |
0.315 |
|
Multiparous, n (%) |
13 (32.5) |
9 (22.5) |
0.315 |
There were differences in menstrual and reproductive patterns between the two groups as assessed. Women with endometriosis were more likely to have chronic pelvic pain, while women with adenomyosis were more likely to have heavy menstrual bleeding. There were no statistically significant differences in other menstrual/reproductive features (Table 2).
Table 2. Menstrual and reproductive characteristics of study participants
|
Variable |
Adenomyosis (n=40) |
Endometriosis (n=40) |
p-value |
|
Regular menstrual cycles, n (%) |
25 (62.5) |
29 (72.5) |
0.340 |
|
Irregular menstrual cycles, n (%) |
15 (37.5) |
11 (27.5) |
0.340 |
|
Dysmenorrhea, n (%) |
28 (70.0) |
32 (80.0) |
0.298 |
|
Chronic pelvic pain, n (%) |
18 (45.0) |
29 (72.5) |
0.014 |
|
Heavy menstrual bleeding, n (%) |
24 (60.0) |
10 (25.0) |
0.002 |
|
Previous pregnancy, n (%) |
16 (40.0) |
11 (27.5) |
0.230 |
|
Previous miscarriage, n (%) |
8 (20.0) |
6 (15.0) |
0.556 |
The ultrasonographic findings were also variable, and among women with endometriosis, the most common finding was ovarian endometrioma, whereas the most common finding among women with adenomyosis was diffuse involvement. Unilateral involvement was more common than bilateral (Table 3).
Table 3. Clinical and ultrasonographic characteristics according to diagnosis
|
Characteristic |
Adenomyosis (n=40) |
Endometriosis (n=40) |
|
Diffuse adenomyosis, n (%) |
24 (60.0) |
|
|
Focal adenomyosis, n (%) |
16 (40.0) |
|
|
Myometrial cysts, n (%) |
27 (67.5) |
|
|
Asymmetrical myometrial thickening, n (%) |
25 (62.5) |
|
|
Junctional zone irregularity, n (%) |
29 (72.5) |
|
|
Ovarian endometrioma, n (%) |
|
25 (62.5) |
|
Superficial peritoneal endometriosis, n (%) |
|
9 (22.5) |
|
Deep infiltrating endometriosis, n (%) |
|
6 (15.0) |
|
Unilateral ovarian involvement, n (%) |
|
17 (68.0) |
|
Bilateral ovarian involvement, n (%) |
|
8 (32.0) |
|
Endometrioma diameter (cm), mean ± SD |
|
4.1 ± 1.3 |
Comparison of ovarian reserve parameters demonstrated significantly lower serum AMH levels and AFC among women with endometriosis compared with those with adenomyosis. This difference was observed in both right and left ovarian follicular counts (Table 4).
Table 4. Comparison of ovarian reserve markers between study groups
|
Ovarian reserve parameter |
Adenomyosis (n=40) |
Endometriosis (n=40) |
p-value |
|
Serum AMH (ng/mL), mean ± SD |
3.42 ± 1.26 |
2.08 ± 1.14 |
<0.001 |
|
Total AFC, mean ± SD |
8.15 ± 2.61 |
5.92 ± 2.34 |
<0.001 |
|
Right ovarian AFC, mean ± SD |
4.12 ± 1.42 |
3.01 ± 1.29 |
<0.001 |
|
Left ovarian AFC, mean ± SD |
4.03 ± 1.51 |
2.91 ± 1.35 |
0.001 |
The correlation analysis showed a strong positive correlation between AFC and serum AMH levels in both groups, which suggests a correlation between biochemical and sonographic assessment of ovarian reserve (Table 5).
Table 5. Correlation between serum AMH levels and antral follicle count
|
Study group |
Correlation coefficient (r) |
p-value |
|
Adenomyosis (n=40) |
0.672 |
<0.001 |
|
Endometriosis (n=40) |
0.741 |
<0.001 |
|
Overall population (N=80) |
0.701 |
<0.001 |
Multivariable analysis showed that the diagnostic group and age were independently associated with serum AMH levels, while BMI and duration of infertility did not significantly predict AMH levels. Bilateral endometrioma was also associated with lower AMH levels in the regression model (Table 6).
Table 6. Multiple linear regression analysis of factors associated with serum AMH
|
Variable |
Regression coefficient (β) |
95% CI |
p-value |
|
Age (years) |
-0.082 |
-0.121 to -0.043 |
<0.001 |
|
BMI (kg/m²) |
-0.031 |
-0.076 to 0.014 |
0.174 |
|
Duration of infertility (years) |
-0.064 |
-0.132 to 0.004 |
0.064 |
|
Endometriosis (vs. adenomyosis) |
-1.102 |
-1.598 to -0.606 |
<0.001 |
|
Bilateral endometrioma |
-0.438 |
-0.831 to -0.045 |
0.030 |
The present study compared ovarian reserve between infertile women with adenomyosis and endometriosis using serum anti-Müllerian hormone (AMH) and antral follicle count (AFC). The findings demonstrated significantly lower AMH levels and AFC among women with endometriosis compared with those with adenomyosis. These findings suggest a greater degree of ovarian reserve impairment in the endometriosis group. Yin et al. (2024) reviewed 150 women, with 58 women having adenomyosis, 36 women having ovarian endometriosis, and 56 women as healthy controls. The mean AMH levels observed were 3.78 ± 1.08 ng/mL for adenomyosis and 1.25 ± 1.34 ng/mL for ovarian endometriosis, whereas the mean AFC levels were 8.05 ± 2.49 and 2.53 ± 1.19, respectively. Their results also support the findings of this study that women with ovarian endometriosis have a greater reduction in their ovarian reserve.[8]
The lower ovarian reserve found in women with endometriosis was also similar to the cross-sectional study of 656 women who were evaluated for infertility, including 71 women with endometriosis, conducted by Abow-Mohamed et al. (2022). They found that women with endometriosis had significantly lower AMH and AFC when compared to women without endometriosis. The relationship between decreased AFC and endometriosis was found in all age groups, while that of AMH was more apparent in women over 35 years old. This underscores the need to take into account age when evaluating ovarian reserve markers in women with endometriosis. In this study, women with adenomyosis also exhibited relatively reduced markers of ovarian reserve compared with women generally but were not directly compared with women who did not have adenomyosis.[14] In a prospective cohort of 1,037 women undergoing ART, Alson et al. (2024) found significantly reduced median AMH and AFC in women with direct ultrasonographic features of adenomyosis compared with women without any features of adenomyosis. They also found that adenomyosis might be linked to changes in ovarian reserve. The strength of this relationship, however, may vary according to the type of sonographic characteristics and the disease phenotype.[15]
The connection between adenomyosis and ovarian reserve is not the same in all studies. In a retrospective study of 374 women with unexplained infertility, Arlıer et al. (2025) did not observe any significant difference in AMH or AFC between women with and without adenomyosis. This is in contrast to the diminished ovarian reserve markers observed in our adenomyosis cohort and indicates that the relationship might differ based on diagnostic criteria, patient characteristics, and the disease phenotype. Variations may also be due to differences in the study populations and inclusion of women receiving assisted reproductive treatment.[16] In the study by Alson et al. (2024), 1040 women who had their first IVF/ICSI cycle were analyzed for the study of endometriosis. Women who had deep infiltrating endometriosis and/or ovarian endometrioma had significantly fewer AFC than those who did not have these findings. The study also reported that their median serum AMH was lower in the affected group.[17] Our findings are consistent with these and lend support to the connection between the extent of ovarian involvement in endometriosis and diminished ovarian reserve. Their study, however, was not a direct comparison between adenomyosis and endometriosis, but rather focused on the reproductive treatment outcome.
Likewise, Lu et al. (2025) did a retrospective evaluation of 3,256 women with IVF/ICSI, of which 300 women had ovarian endometriosis. They found that women with ovarian endometriosis had significantly lower levels of AMH and AFC than women without ovarian endometriosis. Their findings indicate that we are seeing reduced markers of ovarian reserve in the endometriosis group, which we also observed. They also pointed out the role played by age and AMH in assessing reproductive outcomes in women with ovarian endometriosis.[18] In the current study, serum AMH showed a significant positive correlation with AFC in both groups, both diagnostic and non-diagnostic. The consistency of the information provided by biochemical and ultrasonographic tests suggests that these tests can be used together to assess ovarian reserve. In the retrospective study by Feng et al. (2025), AMH also showed a significant positive association with total AFC in women with endometriosis.[9]
In addition to these factors, there is some controversy regarding the effect that ovarian endometriomas and their treatment have on ovarian reserve. In a prospective cohort study with 55 women who had laparoscopic removal of endometrioma, Takmaz et al. (2024) noted significant decreases in AMH and AFC 6 months after surgery regardless of when they were operated on in their menstrual cycle.[19] In a prospective longitudinal study of 80 women with endometrioma and 20 healthy controls, Aslan et al. (2025) found a decrease in serum AMH in all groups of women with endometrioma, greater in surgery patients. These findings highlight the importance of documenting previous ovarian surgery and endometrioma characteristics when interpreting ovarian reserve measurements.[20] The association between endometrioma characteristics and ovarian reserve has also been investigated by Younis et al. (2026) in a systematic review and meta-analysis of 16 studies involving 1,484 women. However, their analysis showed no association between the diameter of the endometrioma and the serum AMH level when the age factor was taken into consideration. This indicates that a decrease in ovarian reserve may not be sufficient to be explained by cyst size.[21] In our study, bilateral endometrioma was associated with lower AMH levels in the regression analysis; however, this finding should be interpreted cautiously because of the limited sample size and the need for appropriate subgroup analysis.
The present study revealed that age and endometriosis were independent predictors of lower serum AMH levels, while BMI and duration of infertility were not statistically significant. The association between age and ovarian reserve is consistent with the findings of Abow-Mohamed et al., (2022) and Feng et al., (2025).[9] However, the cross-sectional study does not prove causality, and it shows the ovarian reserve decline rate across time. In summary, our results showed that the AMH and AFC levels were lower in infertile women with endometriosis compared to those with adenomyosis. Assessment of both markers may therefore provide useful information during infertility evaluation, although further studies involving larger populations and standardized disease classification are required to confirm these differences.
Limitations
There were several limitations to this study. Its cross-sectional design did not allow assessment of changes in ovarian reserve over time or establish a causal relationship between the studied conditions and ovarian reserve impairment. This small sample size and single-center design may restrict the generalizability of the results. In addition, endometriosis is a heterogeneous disease, and the severity of the condition, location of endometriosis, and nature of the endometrioma may affect the ovarian reserve. Finally, there was no healthy control group to compare the findings of these women with women who were not affected by these conditions. These results should be confirmed in larger multicenter prospective studies.
Women with endometriosis who were infertile had significantly lower AFC and serum AMH compared to women with adenomyosis. There was a significant positive correlation between AMH and AFC in both groups, which confirmed that biochemical and ultrasonographic evaluation of ovarian reserve complement each other. Age and endometriosis were independently associated with lower AMH levels. These findings suggest that ovarian reserve assessment should be considered during the evaluation of infertile women with these conditions, particularly those with endometriosis. However, prospective studies involving larger populations are required to confirm these observations.